Yes, they do $NWBO
A personalized treatment that has virtually no negative side effects. People given a death sentence are alive 5, 10, 20+ years. A beautiful 16 girl given no options is now 19 years old and she has NO sign of cancer! I see zero justification for DCVAX-L to not be approved! Don't people with no hope deserve some hope?
1
264
JohnnyDeeze retweeted
$NWBO It was a battle yesterdsy. Above average volume of 6.3 million. Nice close above 0.15. It is absolutely obvious, the desperation to keep the price from rising. The shorts must have a very high count of FTDs , behaving this way. Who in the world would still try to short a 15 cents stock for a financial gain? They need hiiiiiigh volume days, 100 million days on to cover. That’s why they keep it low. The amount of shares shorted must be gigantic. Why else this strategy and struggle at 15 cents. This will have huge moves. Big Pharma had paid tens of billions for a chance in proof of concept. DCVAX is effective, safe and now scalable, applicable to potentially all cancers, trials speak the results, combos speak the results, brain power talent is joining the team, manufacturing cooperation with government run organizations, and this trades below 300 million market cap. Just keep buying with your lunch money. If you don’t see it, stop investing anywhere . This is beyond obvious
.@JoeyB paints a masterpiece 🎨
One Game, One Lens: Jeremy Nieves
One Game, One Lens: Steelers vs. Bengals
10
JohnnyDeeze retweeted
MHRA and SFDA just signed an MOU for closer cooperation on advanced therapies, biologics, and rare diseases, including information exchange and regulatory standards.
DCVax-L is exactly that: an autologous dendritic cell ATMP for an orphan indication. $NWBO already has a non-binding MOU with SPIMACO to pursue Saudi approval and commercialization, with SPIMACO handling the SFDA side.
The UK MAA is still under active review. This doesn’t decide or accelerate it. What it does is build a thicker regulatory bridge so a future SFDA filing can more readily lean on UK work and shared data once the UK clears.
FUDpackers will say nothing matters until approval. The facts are the company already lined up the commercial partner, and the two regulators just made the pathway between them more practical.
#DCVaxWorks
The MHRA and the Saudi SFDA just signed an MOU at the DIA-MHRA Summit:
lnkd.in/p/dZEZR7uv
#gbm #glioblastoma #dcvax $nwbo
BeProactive
FreezeYourTumor
GetDCVax
QualityOfLifeMatters
investorshub.advfn.com/board…
JohnnyDeeze retweeted
The #CFBPlayoff committee had NEVER ranked a 4 loss team in their week 12 playoff rankings.
But TONIGHT they did it, FOUR TIMES. Just coincidentally all four are from the SEC.
JohnnyDeeze retweeted
$NWBO
@NorthwestBio’s DCVax platform saved Brad Silver’s life.
More than 20 years ago he was diagnosed with glioblastoma and given 2 months to live.
Then he met Dr Linda Liau and Dr. Robert M. Prins at @UCLAStrokeNSG and was accepted into a clinical trial for DCVax.
DCVax is a non-toxic promising Phase 3 treatment for glioblastoma and all solid tumors.
Thanks @peter_brit for the find.
#dcvax $nwbo #gbm
A lovely and moving video of Linda Liau and survivors from The UCLA Visionary Ball
During this section, three grateful Neurosurgery patients, our “Points of Light,” shared their incredible stories.
instagram.com/reel/C0kqFdpJp…
investorshub.advfn.com/board…
JohnnyDeeze retweeted
Replying to @JG_Nuke
Michael Intrator $CRWV CEO dumps ~ $1B in stock yet Wall Street and Silicon Valley calls them "visionaries" or "pioneers."
Meanwhile a biotech CEO like $NWBO Linda Powers holds hundreds of millions of locked-up shares, lends her own cash to the company at 0% interest, yet @adamfeuerstein villainizes her after actually saving cancer patients.
Watch what insiders DO with their own money not what some talking head crank says on social media or CNBC.
JohnnyDeeze retweeted
Our highest-graded FBS RBs this season:
Cole Tabb, Cincinnati: 96.8
Nate Sheppard, Duke: 93.6
Caleb Hawkins, Oklahoma State: 90.6
Dwight Phillips Jr., Georgia: 89.6
Jahiem White, North Texas: 88.7
Wayshawn Parker, Utah: 88.1
Nolan James Jr., Notre Dame: 87.9
Keyjuan Brown, Louisville: 87.8
Jamal Rule, Nebraska: 87.6
Cardae Mack, Arizona State: 87.2
Dylan Riley, Boise State: 87.0
Aiden Flora, Iowa State: 86.4
Javian Mallory, Miami (FL): 86.4
Wayne Knight, UCLA: 86.1
Jonaz Walton, Notre Dame: 85.7
JohnnyDeeze retweeted
The MHRA and the Saudi SFDA just signed an MOU at the DIA-MHRA Summit:
lnkd.in/p/dZEZR7uv
#gbm #glioblastoma #dcvax $nwbo
BeProactive
FreezeYourTumor
GetDCVax
QualityOfLifeMatters
investorshub.advfn.com/board…
RT @ActionNetworkHQ: Ja'Marr Chase really has 11 receptions for 230 yards but can't find the end zone for anytime TD (-120) bettors 🫠 https…
JohnnyDeeze retweeted
Ja'Marr Chase becomes the first player to have 130+ receiving yards in the first half of a game since...
Ja'Marr Chase last week.
JohnnyDeeze retweeted
Joe Burrow is carried by his receivers but has thrown a touchdown to Drew Sample, Chase Brown and Dohnte Myers a former DoorDasher and CFL player
JohnnyDeeze retweeted
Replying to @DonDonjarvis101
The MHRA understands it fine. What changed is the alternative.
The UK bet its cancer vaccine strategy on mRNA, signing BioNTech to treat up to 10,000 patients by 2030. That bet has gone badly. The colorectal trial that recruited through the NHS's own Launch Pad was shut down in August with more deaths in the vaccine arm. The head and neck vaccine missed on progression in October. mRNA's Phase 3 win came in melanoma, a hot tumor, and only alongside Keytruda. DCVax-L extended survival in glioblastoma, about as cold as a tumor gets, with no checkpoint inhibitor.
Now look at what the NHS did. After months of joint work, NHS Blood and Transplant is collecting and processing cells for DCVax-L, starting in Leeds and Oxford with plans to expand across England. Its own announcement calls it a treatment for GBM "as well as all solid tumours." A government health body does not put its name beside an OTC-listed biotech and plan a national collection network for compassionate-use volumes.
That is the signal. The MHRA is already on board. What's left is logistics.
























